Skip to content

EMBRACE CHANGE ACQUISITION CORP.: 10-Q filed 2025-12-10

What EMBRACE CHANGE ACQUISITION CORP. reported in its quarterly report filed 2025-12-10 (fiscal Q3 2025): 19 published measures, 66 facts as tagged in accession 0001493152-25-027065.

This filing

Form
10-Q (quarterly report)
Filed
2025-12-10
Fiscal period
fiscal Q3 2025
Accession
0001493152-25-027065 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All EMBRACE CHANGE ACQUISITION CORP. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2025-09-3027,495,839USD
At 2024-12-3126,154,194USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2025-09-3033,674,492USD
At 2024-12-315,890,908USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2025-09-30-7,375,683USD
At 2025-06-30-6,706,690USD
At 2025-03-31-6,180,910USD
At 2024-12-31-5,823,923USD
At 2024-09-30-5,749,677USD
At 2024-06-30-4,920,324USD
At 2024-03-31-4,842,397USD
At 2023-12-31-4,114,096USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2025-07-01 to 2025-09-3018,447USD92
2025-01-01 to 2025-09-30-169,811USD273
2025-04-01 to 2025-06-30-98,634USD91
2025-01-01 to 2025-03-31-89,624USD90
2024-07-01 to 2024-09-30227,631USD92
2024-01-01 to 2024-09-301,212,138USD274
2024-04-01 to 2024-06-30677,230USD91
2024-01-01 to 2024-03-31307,277USD91

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2025-01-01 to 2025-09-30-411,554USD273
2024-01-01 to 2024-09-30-407,780USD274

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2025-01-01 to 2025-09-30900,000USD273
2024-01-01 to 2024-09-30-32,105,738USD274

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2025-01-01 to 2025-09-30-550,000USD273
2024-01-01 to 2024-09-3032,521,263USD274

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2025-09-30-7,375,913USD
At 2024-12-31-5,824,153USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2025-07-01 to 2025-09-303,379,946shares92
2025-01-01 to 2025-09-304,135,822shares273
2024-07-01 to 2024-09-306,129,379shares92
2024-01-01 to 2024-09-306,988,761shares274

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2025-07-01 to 2025-09-303,379,946shares92
2025-01-01 to 2025-09-304,135,822shares273
2024-07-01 to 2024-09-306,129,379shares92
2024-01-01 to 2024-09-306,988,761shares274

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2025-07-01 to 2025-09-300.01USD/shares92
2025-01-01 to 2025-09-30-0.04USD/shares273
2024-07-01 to 2024-09-300.04USD/shares92
2024-01-01 to 2024-09-300.17USD/shares274

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2025-07-01 to 2025-09-300.01USD/shares92
2025-01-01 to 2025-09-30-0.04USD/shares273
2024-07-01 to 2024-09-300.04USD/shares92
2024-01-01 to 2024-09-300.17USD/shares274

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2025-07-01 to 2025-09-30-267,843USD92
2025-01-01 to 2025-09-30-998,347USD273
2024-07-01 to 2024-09-30-350,840USD92
2024-01-01 to 2024-09-30-478,567USD274

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2025-09-3026,681USD
At 2024-12-3166,985USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2025-07-01 to 2025-09-301,150USD92
2025-01-01 to 2025-09-303,413USD273
2024-07-01 to 2024-09-303,513USD92
2024-01-01 to 2024-09-303,513USD274

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2025-09-3030,708,492USD
At 2024-12-312,924,908USD

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2025-09-302,295,893shares
At 2024-12-312,295,893shares

Cash including restricted cash

Cash, cash equivalents and restricted cash as reported in the cash flow reconciliation. Restricted amounts are not freely available, so this is not the same as unrestricted cash.

PeriodValueUnitDays
At 2025-09-305,431USD
At 2024-12-3166,985USD
At 2024-09-3013,053USD
At 2023-12-315,308USD

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2025-07-01 to 2025-09-30286,290USD92
2025-01-01 to 2025-09-30828,536USD273
2024-07-01 to 2024-09-30578,471USD92
2024-01-01 to 2024-09-301,690,705USD274

Inspect the source

Entity
EMBRACE CHANGE ACQUISITION CORP. / CIK 0001869601
Captured
2026-09-21T17:22:30.740Z
SEC response SHA-256
a7e7c405da5b6e0be955206d48bae200dfcc6dd12a32d784435cefeac5bb258a

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001869601.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))